DynaVox Inc. Cl A (DVOXQ) Financials Nov 14, 2014, 8:10

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
DynaVox Inc. Cl A (DVOXQ) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for DynaVox Inc. Cl A


Fiscal year is July-June. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 91.16M 25.8M 108.1M 97.32M 64.95M
Cost of Goods Sold (COGS) incl. D&A 24.83M 6.27M 32.7M 27.97M 19.79M
COGS excluding D&A 22.18M 5.51M 28.34M 24.13M 16.61M
Depreciation & Amortization Expense 2.65M 760,000 4.36M 3.84M 3.17M
Depreciation 2.19M 583,000 3.38M 2.99M 1.93M
Amortization of Intangibles 468,000 177,000 981,000 854,000 1.24M
Gross Income 66.33M 19.54M 75.41M 69.35M 45.17M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 46.89M 13.08M 63.94M 59.99M 46.25M
Research & Development 6.89M 2.19M 9.89M 7.13M 6.76M
Other SG&A 40.01M 10.88M 54.05M 52.86M 39.49M
Other Operating Expense 0 0 0 0 0
Unusual Expense 1.59M 2.53M 1.34M 66.93M (36.87M)
EBIT after Unusual Expense (1.59M) (2.53M) (1.34M) (66.93M) 36.87M
Non Operating Income/Expense (518,000) (10,000) 513,000 (107,000) (108,000)
Non-Operating Interest Income 111,000 12,000 36,000 28,000 38,000
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 8.42M 440,000 2.65M 2.29M 2M
Gross Interest Expense 8.42M 440,000 2.65M 2.29M 2M
Interest Capitalized 0 0 0 3,000 0
Pretax Income 9.02M 3.49M 8.03M (59.94M) 33.72M
Income Tax 181,000 592,000 1.36M (3.61M) 49.67M
Income Tax - Current Domestic - 10,000 310,000 167,000 97,000
Income Tax - Current Foreign - 21,000 95,000 16,000 45,000
Income Tax - Deferred Domestic - 626,000 1.37M (4.47M) 49.52M
Income Tax - Deferred Foreign - (65,000) (418,000) 682,000 0
Income Tax Credits - 0 0 0 0
Equity in Affiliates - 0 0 0 0
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income 8.84M 2.9M 6.67M (56.33M) (15.95M)
Minority Interest Expense - 2.4M 5.44M (37.88M) (6.42M)
Net Income 8.84M 505,000 1.23M (18.45M) (9.53M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations - 0 0 0 0
Net Income After Extraordinaries 8.84M 505,000 1.23M (18.45M) (9.53M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 8.84M 505,000 1.23M (18.45M) (9.53M)
EPS (Basic) - 0.05 0.13 (1.76) (0.84)
Basic Shares Outstanding - 9.38M 9.38M 10.49M 11.3M
EPS (Diluted) - 0.05 0.13 (1.76) (0.84)
Diluted Shares Outstanding - 9.69M 9.38M 10.49M 11.3M
EBITDA 22.09M 7.22M 15.83M 13.2M 2.09M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors of Sage Therapeutics Have Chance to Join Lawsuit

Updated Category News Views 88

Introduction to the Class Action Lawsuit Attention, investors! There's an important opportunity arising for shareholder litigation against Sage Therapeutics, Inc. The legal firm Bronstein, Gewirtz & Grossman, LLC is officially notifying individuals who have invested in Sage Therapeutics about a class action lawsuit that has now been filed. If you have faced substantial...

Continue Reading
FARO Technologies Revolutionizes 3D Metrology with Leap ST

Updated Category News Views 105

FARO Technologies Enhances 3D Metrology with Leap ST FARO Technologies, Inc. (NASDAQ: FARO) is pushing the boundaries of handheld scanning technology with the introduction of the Leap ST. This launch marks a significant expansion of FARO's product portfolio, positioning the company among the few firms offering a comprehensive range of portable 3D metrology solutions. Leap...

Continue Reading
Strong Financial Performance and Growth Strategies at TORM PLC

Updated Category News Views 181

TORM PLC Reports Robust Q3 2025 Financial Results TORM PLC has demonstrated remarkable resilience and adaptability, reporting its strongest quarterly results in 2025. This achievement underscores the effectiveness of TORM's integrated operating model, as highlighted by the CEO. The company continues to prioritize creating long-term value for its shareholders while...

Continue Reading
Manhattan Associates Faces Legal Challenges Amid Shareholder Losses

Updated Category News Views 304

Manhattan Associates Faces Legal Challenges Following Shareholder Loss In recent developments, Manhattan Associates, Inc. (NASDAQ: MANH) is under scrutiny as a class action lawsuit has been filed against the company. This action comes after an alarming drop in shareholder value, amounting to over $4 billion. The lawsuit is pivotal as it involves allegations of misleading...

Continue Reading
BioLife Solutions Announces Upcoming Financial Results

Updated Category News Views 91

BioLife Solutions to Share Key Financial Insights BioLife Solutions, Inc. (NASDAQ: BLFS), a pioneering developer and supplier of bioproduction products and services specializing in cell and gene therapies, is gearing up for a significant event. The company plans to release its financial results for the third quarter of 2024 after market hours on November 12, 2024. This is...

Continue Reading